This site is intended for U.S. healthcare professionals.
Menu
Close
First-line Advanced RCC
Overview
Efficacy Measures: OS, PFS, & ORR
Safety & Tolerability Profile
Dosing
Therapy Management Strategies
MOAs – INLYTA and pembrolizumab
NCCN Recommendation
Publications
Health Care Provider Videos
Professional Resources
Second-line Advanced RCC
Overview
Efficacy Measures: PFS, ORR, OS, & Subset
Analyses
Safety & Tolerability Profile
Patient Characteristics & Treatment
Considerations
Oral Dosing
VEGFR Pathway & INLYTA® (axitinib) MOA
NCCN Recommendation
Professional Resources
Patient Support and Resources
Pfizer Oncology Together
Vouchers
Events
Materials
Videos
Making your patients’ support needs a priority. Together.
At Pfizer Oncology Together™, patient support is at the core of everything we do. We’ve gathered resources and developed tools to help patients and their loved ones throughout INLYTA® (axitinib) treatment. From helping to identify financial assistance options to connecting patients to resources for emotional support, your patients’ needs are our priority.
Pfizer Oncology Together can help patients understand their insurance benefits and connect them with financial assistance resources, regardless of their insurance coverage.
Resources for eligible patients with commercial, private, employer, and state health insurance marketplace coverage:
Co-pay assistance: Eligible, commercially insured patients may pay as little as $0 per month for INLYTA. Limits, terms, and conditions apply*
For more information, see your Pfizer Oncology representative or visit PfizerOncologyTogether.com.
*Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. Patients may receive up to $25,000 per product in savings annually. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Pfizer reserves the right to rescind, revoke, or amend this offer without notice. For full Terms and Conditions, please see PfizerOncologyTogether.com/terms. For any questions, please call 1-877-744-5675, visit PfizerOncologyTogether.com/terms or write: Pfizer Oncology Together Co-Pay Savings Program, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.
MEDICARE/GOVERNMENT INSURED
Help identifying resources for eligible patients with Medicare/Medicare Part D, Medicaid, and other government insurance plans:
UNINSURED
Help identifying resources for eligible patients without any form of healthcare coverage:
†If support from independent charitable foundations or Medicare Extra Help is not available, Pfizer Oncology Together will provide eligible patients with medication for free through the Pfizer Patient Assistance Program. The Pfizer Patient Assistance Program is a joint program of Pfizer Inc. and the Pfizer Patient Assistance Foundation™. The Pfizer Patient Assistance Foundation is a separate legal entity from Pfizer Inc. with distinct legal restrictions.
‡The Pfizer Savings Program is not health insurance. For more information, call the toll-free number 1-877-744-5675. There are no membership fees to participate in this program. Estimated savings are 50% and depend on such factors as the particular drug purchased, amount purchased, and the pharmacy where purchased.
Access & Reimbursement Support
If patients prescribed INLYTA need access or reimbursement support, Pfizer Oncology Together is here to help with:
Personalized Patient Support
When your patients need support for their day-to-day challenges, we want to be a place they can turn to for help. At Pfizer Oncology Together, our Care Champions, who have social work experience, can connect patients prescribed INLYTA to resources that may help with some of their daily needs.§
Call 1-877-744-5675 (Monday-Friday 8 AM-8 PM ET)
§Some services are provided through third-party organizations that operate independently and are not controlled by Pfizer. Availability of services and eligibility requirements are determined solely by these organizations.
Pfizer Oncology Together Co-Pay Savings Program
Terms and Conditions
By using this co-pay card, you acknowledge that you currently meet the eligibility criteria and will comply with the Terms and Conditions described below:
BAVENCIO is a registered trademark of Merck KGaA, Darmstadt, Germany. All other trademarks are property of their respective owners.
INLYTA® (axitinib) in combination with pembrolizumab is indicated for the first-line treatment of patients with advanced renal cell carcinoma (RCC).
Please see full Prescribing Information.
OK. We'll need you to sign in before we can determine if you are aligned with a sales representative.
If you select 'Yes', you will be required to enter your username and password in the sign-in form that will appear over this window.
Would you like to sign in now?